SavedAdd your journal

Journals / Medicine Science / 2019 / Cilt: 8 - Sayı: 2

Frequency of lysosomal acid lipase deficiency in patients with primary hyperlipidemia

Bahri EVREN
Yılmaz BİLGİC
Feyza FİRAT ATAY
Ayse Nuransoy CENGİZ
Yasir Furkan CAGİN
Pages
260–262
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, in this context, there is a need to work with a large number of patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of our study was to investigate the prevalence of LAL (lysosomal acid lipase) deficiency in patients with primary hyperlipidemia.
📊
Key Findings & Data:Twenty-four patients with primary hyperlipidemia were included in the study.
💡
Conclusion & Impact:However, in this context, there is a need to work with a large number of patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

The aim of our study was to investigate the prevalence of LAL (lysosomal acid lipase) deficiency in patients with primary hyperlipidemia. Twenty-four patients with primary hyperlipidemia were included in the study. The gender, age, height, weight, body mass index and waist circumference of the patients were recorded. Lipid profiles, glucose, transaminases and LAL enzyme profiles were evaluated. LAL enzyme deficiency was not detected in patients with primary hyperlipidemia. In our study, when we investigated LAL deficiency in primary hyperlipidemic patients, we could not find a relationship between them. As a result of our study, LAL deficiency was not detected in patients with primary hyperlipidemia. However, in this context, there is a need to work with a large number of patients.

🔖

Cite This Article

EVREN, B., BİLGİC, Y., ATAY, F. F., CENGİZ, A. N., CAGİN, Y. F. (2019). Frequency of lysosomal acid lipase deficiency in patients with primary hyperlipidemia. Medicine Science, Cilt: 8 - Sayı: 2, 260–262. https://ajindex.com/articles/277101

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Zeynep Büşra Aksoy, Ege soydemir. Lizozomal aktivite. Güncel Gastroenteroloji. 2016;4:345-52.
  2. Futerman AH, Van Meer G. The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol. 2004;5:554-65.
  3. Bernstein DL, Hulkova H, Bialer MG, et al. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol. 2013;58:1230-43.
  4. Botero V, Garcia VH, Gomez-Duarte C, et al. Lysosomal acid lipase deficiency, a rare pathology: The first pediatric patient reported in colombia. Am J Case Rep. 2018;19:669-72. Andria, g. & parini, Lysosomal storage diseases early diagnosıs and new treatments edited by: rossella parini, generoso andriat. lysosomal storage d apa (american psychological assoc.). 2010. Lipiński P, Ługowska A, Zakharova EY, et al. Diagnostic algorithm for cholesteryl ester storage disease: Clinical presentation in 19 Polish Patients. J Pediatr Gastroenterol Nutr. 2018;67:452-47. Wierzbicka-Rucińska A, Jańczyk W, Ługowska A, et al. Diagnostic and therapeutic management of children with lysosomal acid lipase deficiency (LAL-D). Review of the literature and own experience. Dev Period Med. 2016;20:212-5.
  5. Hamilton J, Jones I, Srivastava R, et al. A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2. Clin Chim Acta. 2012;413:1207-10.
  6. Canbay A, Müller MN, Philippou S, et al. Cholesteryl ester storage disease: fatal outcome without causal therapy in a female patient with the preventable sequelae of progressive liver disease after many years of mild symptoms. Am J Case Rep. 2018;19:577-81.